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Received February 10, 2015; accepted September 9, 2015AbstractBackground: Laryngotracheobronchial anomalies (LTBAs) may cause respiratory problems during early childhood, and increase the risk of
hospitalization or mortality in diseased children. This study investigated the initial hospitalization age and risk factors for in-hospital mortality in
infants diagnosed with LTBAs during their first 5 years of life.
Methods: Hospitalized infants diagnosed with LTBAs were retrieved from Taiwan's National Health Insurance Research Database from 2003 to
2005. Their medical claim data were traced up to 59 months of age. The age distribution of all LTBA cases was analyzed, and then the enrolled
infants were grouped into two age groups. Hospitalization-related comorbidities and risk factors for in-hospital mortality were also analyzed.
Results: A total of 1272 LTBA cases were retrieved. Most of them (976, 76.7%) were initially hospitalized at an age of 0e3 months, and 47
infants (3.7%) died. These enrolled cases were grouped into early and late LTBA groups, with ages of 0e3 months and 4e11 months,
respectively. Patients in the late LTBA group had significantly more acute airway infections/asthma and neurological diseases, more frequent
hospitalizations, longer hospitalization stay, and higher in-hospital mortality than did the early LTBA group ( p < 0.001). The adjusted odds
ratios (aORs) for in-hospital mortality were significantly higher in the children aged 4e11 months [aOR ¼ 2.50, 95% confidence intervals (CI):
1.36e4.60], or having perinatal disease (aOR ¼ 2.00, 95% CI: 1.07e3.73), cardiovascular disease (aOR ¼ 2.45, 95% CI: 1.30e4.60), other
congenital anomalies (aOR ¼ 2.42, 95% CI: 1.28e4.60), and neurological diseases (aOR ¼ 2.32, 95% CI: 1.18e4.53).
Conclusion: Most infants with LTBAs were initially diagnosed and hospitalized when they were aged 3 months or younger. The risk factors for
in-hospital mortality of the children with LTBAs included being diagnosed and treated at an age of 4 months and older, and the presence of
perinatal disease, cardiovascular anomalies, other congenital anomalies, neurological diseases, and an age of 4 months and older.
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Laryngotracheobronchial anomalies (LTBAs) may cause
different degrees of respiratory problems which are usually
more severe when patients are younger, due to their narrower
sizes of airways. These patients may suffer from respiratory
distress and airway infections, and require frequent hospitali-
zations, especially in severe cases. The life quality and growth
of the diseased children can be influenced, and the family's
burden can be increased. Sometimes, it is a challenge for pe-
diatricians to take care of infants with severe LTBAs. Since
LTBAs are not rare among childrenwith pulmonary diseases, an
investigation of their hospitalization features and risk factors of
mortality during early childhood is important for future care.
LTBAs are heterogeneous diseases including absence,
atresia, stenosis and diverticulum of the airway, cartilage
anomalies, congenital cleft thyroid and cartilage, laryngocele,
and congenital laryngeal stridor.1e3 Vocal cord paralysis,
congenital anomalies of large vessels and abnormalities of the
central nervous system may present similar symptoms, and
should be taken into differential diagnosis. In mild forms of
LTBAs, the symptoms are usually mild and self-limiting by the
age of 2 years. Hospitalization is required for patients with
comorbidities and other medical conditions including airway
infections, other congenital anomalies, gastroesophageal or
laryngopharyngeal reflux, and central nervous system dis-
eases.4e11 Although most patients are diagnosed during early
months of life, some are diagnosed during later infancy or
childhood.6,12,13 Different clinical presentations and disease
courses between those diagnosed at early or late infancy periods
have been investigated.11 Most reported studies on children's
LTBAs have focused on airway malacia, the most common type
of LTBAs, and most of them were conducted at a single hospital
and only followed up the patients for a short period of
time.2,4,5,8,11,12,14 Thus, an investigation of the clinical outcomes
of hospitalized children with LTBAs for multicenter cases and
observation for a longer period may provide more information
for pediatricians caring for these patients in the future.
The single-payer National Health Insurance (NHI) program
in Taiwan was launched in 1995 and covered > 99.5% of the
nation's inhabitants.15 The claims data from Taiwan's National
Health Insurance Research Database (NHIRD) have provided
trustworthy information for population-based research in chil-
dren and adults for > 10 years.16e21 Therefore, it is worthwhile
evaluating the clinical outcomes of children with LTBAs using
Taiwan's NHIRD for a nationwide, multicentered investigation.
We hypothesized that the diagnosed ages and the presence
of comorbidities in infants with LTBAs may influence their
clinical outcomes. Therefore, the purpose of this study was to
investigate the diagnostic ages and risk factors for in-hospital
mortality in hospitalized infants diagnosed with LTBAs during
their first 5 years of life.
2. Methods
This study was approved by the Institutional Review Board
of Taipei Veterans General Hospital, Taipei, Taiwan (VGH IRBNo.2012-06-006A). There was no patient consent required
because the data were analyzed anonymously and no personal
information could be connected to the data in this study.2.1. Study populationHospitalization claims data of Taiwan's NHIRD were used
for analysis. The hospitalization claims data contain scrambled
and encrypted personal identification numbers, dates of birth,
gender, diagnostic codes using the International Classification
of Disease, Ninth Revision, Clinical Modification (ICD-9-
CM),22 procedural codes, and admission and discharge dates.
Infants born between 2003 and 2005 and admitted at an age
of 0e11 months with a discharge diagnosis of LTBAs (ICD-9-
CM code: 748.3) were retrieved for analysis. The hospitali-
zation records of all patients were traced until they were
59 months of age. The enrolled infants were grouped into two
age groups according to the findings of age distribution and
compared.
Data on hospitalization frequency, total hospital stay, age at
receiving the earliest bronchoscopy examinations (ICD-9-CM
codes: 31.72, 33.22, 33.23, 33.24, 33.26, 33.27, and 31.72) and
tracheostomy (ICD-9-CM codes: 31.1, 31.21, and 31.29), and
the discharge diagnoses and status were retrieved and
analyzed. Clinical Classification Software (CCS) 2010 version
was used to classify the diagnoses into clinically meaningful
categories.23 Acute airway infections included the diagnoses
of pneumonia, bronchitis, and other upper and lower airway
infections (CCS codes: 122, 125, 133, 134).23Special attention
was also paid to the categories of cardiovascular anomalies
(CCS code: 213), other congenital anomalies (CCS code: 217),
perinatal diseases (CCS code: 224), esophageal diseases (CCS
code: 138), and neurological diseases (including epilepsy and
other central nervous system disease (CCS code: 83) for which
the discharge diagnoses were further classified and analyzed
by the first three digits of the ICD-9-CM codes.22,232.2. Data analysisThe database management software PostgreSQL (version
9.34, The PostgreSQL Global Development Group, Los
Angeles, CA, USA) was used for data processing,24 and SPSS
22.0 (IBM Corp., Armonk, NY, USA) was used for statistical
analysis. The Mann-Whitney U test was used for comparisons
between two groups with continuous variables, and the Chi-
square test was used to compare categorical variables. Lo-
gistic regression modeling was used to analyze the odds ratio
(ORs) for associated factors with the in-hospital mortality rate
among the patients with LTBAs. The decision threshold for
eligibility was p < 0.10 for the univariate model and to remain
in the multivariate model. A p value < 0.05 was used to
determine statistical significance.
3. Results
From the nationwide claims of 11,642,140 hospitalizations,
there were 173,785 (1.5%) infants aged 0e11 months who
Fig. 1. Flow chart of the recruitment process. LTBA¼ laryngotracheobronchial
anomaly.
Fig. 2. Age distribution of the enrolled infants when first diagnosed with
laryngotracheobronchial anomalies. m ¼ months old.
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fants, 1272 (0.7%) were hospitalized with a diagnosis of
LTBA (Fig. 1).Since a total number of 649,343 infants were
born in Taiwan from 2003 to 2005, the incidence of hospi-
talized LTBA was 0.2%.
Among these hospitalized LTBA infants, the median age at
the initial diagnosis of LTBA was 66 days old (approximately
2 months old) (Table 1).Among enrolled infants, there were
976 (76.7%) infants hospitalized and diagnosed at an age of
0e3 months, and 296 (23.3%) infants diagnosed at an age of
4e11 months (Fig. 2). These enrolled infants were grouped to
early (0e3 months old) and late LTBA (4e11 months old)
groups. There were more boys (63.9%) than girls (36.1%),Table 1
Characteristics of the infants diagnosed with laryngotracheobronchial anomalies a
Total
(n ¼ 1272)
Gender
Male, n (%) 813 (63.9)
Female, n (%) 459 (36.1)
Male-to-female ratio 1.8
Age at diagnosis (days old)d 66 (38e115)
Hospitalization frequencyd 3 (2e6)
Total hospitalization daysd 22 (9e49)
Bronchoscopy, n (%) 418 (32.9)
Age at first bronchoscopy (days old)d 59 (34e90)
Tracheostomy, n (%) 6 (0.5)
Age at tracheotomy (days old)d 281 (106e666)
In-hospital mortality, n (%) 47 (3.7)
Age at death (days old)d 278 (134e534)
LTBA ¼ laryngotracheobronchial anomalies.
a Diagnosed at < 120 days of age.
b Diagnosed at age 120 days of age.
c Comparing the early and late LTBA groups.
d median (interquartile range).especially in the late LTBA group ( p < 0.01). Compared to the
early LTBA group, infants of the late LTBA group had a
significantly higher frequency of hospitalization ( p < 0.001)
and longer hospital stay ( p < 0.001) (Table 1).
With regard to the specific diagnostic procedure, only 418
(32.9%) of the infants received bronchoscopic examinations
(Table 1). The median ages at first bronchoscopy were 72 days
old (approximately 2.5 months old) and 188 days old
(approximately 6 months old) in the early and late LTBA
groups, respectively. During the first 5 years of life, only six
(0.5%) of the infants received a tracheostomy, and 47 infants
(3.7%) died in hospital. The late LTBA group had a signifi-
cantly higher mortality rate (7.1%) than the early LTBA group
(2.7%) ( p < 0.001) (Table 1).
According to the first 5 years of hospitalization records of
the enrolled infants, the most common diagnosis during
admission was acute airway infection or asthma (81.4%),
including asthma, pneumonia, bronchitis, and other upper andnd their clinical outcomes during the first 5 years of life.
Early LTBAa
(n ¼ 976)
Late LTBAb
(n ¼ 296)
pc
0.009
605 (62.0) 208 (70.3)
371 (38.0) 88 (29.7)
1.6 2.4
53 (32e78) 182 (141e238) <0.001
3 (2e6) 4 (2e9) <0.001
22 (10e56) 3 4 (11e95) <0.001
322 (33.0) 96 (32.4) 0.858
72 (40e131) 188 (139e242) <0.001
4 (0.4) 2 (0.7) 0.559
263 (103e530) 553 (144e962) 0.533
26 (2.7) 21 (7.1) <0.001
171 (98e339) 359 (252e604) 0.006
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cantly higher percentage of hospitalization-related acute
airway infections/asthma than the early LTBA group (87.2%
vs. 79.6%, p ¼ 0.003) (Table 2). Additionally, there were 248
(19.5%) patients who had previously been hospitalized before
their enrolled hospitalizations, and significantly more patients
in the late LTBA group (36.8%) than in the early LTBA group
(14.2%) ( p < 0.001).
Perinatal diseases (n ¼ 305, 24.0%), cardiovascular
anomalies (n ¼ 295, 23.2%), other congenital anomalies
(n ¼ 206, 16.2%), esophageal diseases (n¼180, 14.2%), and
central nervous system diseases including epilepsy (n ¼ 160,
12.6%) were also not uncommon in the infants with LTBAs.
Respiratory problems and perinatal infections were the most
common perinatal diseases, and there were no significant
differences between the two groups. Most of the cardiovas-
cular anomalies were congenital septal defects (69.8% of all
cardiovascular anomalies). Only 100 (33.9%) of the infants
with cardiovascular anomalies required surgical intervention,
and there was also no significant difference between the two
groups. With regard to congenital anomalies other than car-
diovascular anomalies, musculoskeletal anomalies were most
common, and they tended to be more common in the late than
the early group ( p ¼ 0.079). Although there was no significant
difference in comorbid chromosome anomalies between the
two groups, the percentage of infants with Down syndrome
was significantly higher in the late (3.0%) than the early
(1.1%) LTBA group ( p ¼ 0.020).
One hundred and eighty (14.2%) of the enrolled infants had
comorbid esophageal disease, and it tended to be more com-
mon in the late (17.2%) than the early (13.2%) LTBA group
( p ¼ 0.083) (Table 2). Furthermore, 160 (12.6%) of the
enrolled infants had diseases of the central nervous system or
epilepsy, with significantly more patients in the late (18.2%)Table 2
Hospitalization-related comorbidities in the infants with laryngotracheobronchial a
Total
(n ¼ 1272)
Acute airway infections/asthma, n (%) 1035 (81.4)
Hospitalized earlier than LTBA diagnosis, n (%) 248 (19.5)
Perinatal disease, n (%) 305 (24.0)
Respiratory problem, n (%) 173 (13.6)
Perinatal infection, n (%) 105 (8.3)
Cardiovascular anomaly, n (%) 295 (23.2)
Septal defect, n (%) 206 (16.2)
Receiving cardiac surgery, n (%) 100 (7.9)
Other congenital anomaly, n (%) 206 (16.2)
Musculoskeletal anomaly, n (%) 91 (7.2)
Chromosomal anomaly, n (%) 48 (3.8)
Down syndrome, n (%) 20 (1.6)
Esophageal disease, n (%) 180 (14.2)
Reflux esophageal diseased 176 (13.8)
Neurological disease, n (%) 160 (12.6)
CNS ¼ central nervous system; LTBA ¼ laryngotracheobronchial anomalies.
a Diagnosed at < 120 days of age.
b Diagnosed at  120 days of age.
c Comparing the early and late LTBA groups.
d International Classification of Disease, Ninth Revision, Clinical Modification (than the early (10.9%) group ( p < 0.001). The top five most
common comorbidities at death were cardiac anomalies
(n ¼ 17, 36.2%), respiratory failure (n ¼ 17, 36.2%), septi-
cemia (n ¼ 16, 34.0%), other congenital anomalies (n ¼ 12,
25.5%), and pneumonia (n ¼ 10, 21.3%).
The univariate logistic regression analysis for potential risk
factors associated with in-hospital mortality among the pa-
tients with LTBAs revealed that age at diagnosis of LTBAs,
perinatal diseases, cardiovascular anomalies, other congenital
anomalies, and central nervous system diseases including ep-
ilepsy were significant factors ( p < 0.01). Gender, acute
airway infections or asthma, and esophageal disease were all
not significant ( p > 0.10), so they were excluded from
multivariate analysis. In multiple logistic regression analysis,
the risk-adjusted ORs (aORs) for in-hospital mortality
remained significantly higher in the late group than in the early
group (aOR ¼ 2.50, 95% CI ¼ 1.36e4.60). The presence of
perinatal diseases (aOR ¼ 2.00, 95% CI ¼ 1.07e3.73), car-
diovascular anomalies (aOR ¼ 2.45, 95% CI ¼ 1.30e4.61),
other congenital anomalies (aOR ¼ 2.42, 95%
CI ¼ 1.28e4.60), or neurological disease (epilepsy or other
central nervous system diseases) (aOR ¼ 2.50, 95%
CI ¼ 1.36e4.60) also had significantly higher aORs than in
the children without those diseases (Table 3).
4. Discussion
In this study, we demonstrated that most of the children
with LTBAs were initially hospitalized and diagnosed at an
age of 0e3 months. However, a significantly higher frequency
of hospitalization, longer hospital stay, and higher mortality
rate were found during the first 5 years of life of the infants
diagnosed with LTBAs at an age of 4e11 months. The risk
factors for in-hospital mortality were age at diagnosis ofnomalies during the first 5 years of life.
Early LTBAa
(n ¼ 976)
Late LTBAb
(n ¼ 296)
pc
777 (79.6) 258 (87.2) 0.003
139 (14.2) 109 (36.8) <0.001
233 (23.9) 72 (24.3) 0.873
141 (14.4) 32 (10.8) 0.110
73 (7.5) 32 (10.8) 0.068
222 (22.7) 73 (24.7) 0.494
150 (15.4) 56 (18.9) 0.140
71 (7.3) 29 (9.8) 0.225
149 (15.3) 57 (19.3) 0.103
63 (6.5) 28 (9.5) 0.079
40 (4.1) 17 (5.7) 0.230
11 (1.1) 9 (3.0) 0.020
129 (13.2) 51 (17.2) 0.083
127 (13.0) 49 (16.6) 0.122
106 (10.9) 54(18.2) <0.001
ICD-9-CM) code: 530.81 or 530.11 or 530.1 or 530.8 or 530.10 or 530.2.
Table 3
Odds ratios for in-hospital mortality of the infants with laryngotracheobronchial anomalies during the first 5 years of life.
Discharge status OR (95% CI) p aOR (95% CI)a p
Total n Alive, n (%) Dead, n (%)
Age at the diagnosis of LTBAs
0e3 mo old 976 950 (97.3) 26 (2.7) 1 d 1 d
4e11 mo old 296 275 (92.9) 21 (7.1) 2.79 (1.55e5.04) 0.001 2.50 (1.36e4.60) 0.003
Perinatal disease
No 967 942 (97.4) 25 (2.6) 1 d 1 d
Yes 305 283 (92.8) 22 (7.2) 2.93 (1.63e5.27) <0.001 2.00 (1.07e3.73) 0.030
Cardiovascular anomaly
No 977 954 (97.6) 23 (2.4) 1 d 1 d
Yes 295 271 (91.9) 24 (8.1) 3.67 (2.04e6.61) <0.001 2.45 (1.30e4.61) 0.005
Other congenital anomaly
No 1066 1038 (97.4) 28 (2.6) 1 d 1 d
Yes 206 187 (90.8) 19 (9.2) 3.77 (2.06e6.88) <0.001 2.42 (1.28e4.60) 0.007
Neurological disease
No 1112 1080 (97.1) 32 (2.9) 1 d 1 d
Yes 160 145 (90.6) 15 (9.4) 3.49 (1.85e6.60) <0.001 2.32 (1.18e4.53) 0.014
CNS ¼ central nervous system; LTBA ¼ laryngotracheobronchial anomalies; OR ¼ odds ratio; aOR ¼ adjusted odds ratio.
a Adjusted for all factors other than itself.
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congenital anomalies, and neurological diseases.
In the present study, LTBAs occurred more in male infants,
which is consistent with the results of other studies.1 After
further dividing the patients by age, we found that the male
predominance was more evident in the late group. Male infants
are usually more vulnerable than female infants and may thus
be more liable to LTBAs.25 Nevertheless, the univariate
analysis in the present study did not find a significant influence
of gender on in-hospital mortality.
Whether airway anomalies increase the risk of airway in-
fections is controversial. While Friedman et al26 reported no
increased risk of upper airway infections in patients with any
airway anomaly, Yalcin et al9 reported opposite findings. In
our study, airway infections including pneumonia, bronchitis,
and other upper and lower airway infections were the main
comorbidities, accounting for 81.4% of the enrolled infants.
The reason may be related to abnormal anatomical and his-
tological structures leading to aspiration and high suscepti-
bility to infections.6,9 Physicians should be aware of airway
infections in patients with LTBAs, because we also found that
pneumonia and respiratory failure were important comorbid-
ities at death. Although more cases of the late LTAB group had
acute airway infections, our result did not find it a significant
risk factor for the in-hospital mortality.
Neurological diseases including seizures, developmental
delay, mental retardation, cerebral palsy, microcephaly, and
hypotonia had been reported in 8e48% of infants with airway
malacia,610and our findings (12.6%) are consistent with those
previous reports. It had been hypothesized that airway malacia
is a consequence of an underdeveloped or abnormally inte-
grated central nervous system.6 On the one hand, impaired
vagal nerve function may lead to decreased laryngeal tone, and
on the other hand, neuromuscular hypotonia may cause
collapsed supporting muscles in the pharynx. Both defects are
probably related to laryngotracheal anomalies.6 Most patients
with mild neurological diseases become symptom free withage, however some patients, and especially hypotonic infants,
may have problems with breathing and feeding, and even
require surgical interventions including tracheostomy.6e10 In
the present study, cases that underwent tracheostomy were
<1%, so we could not find any role of tracheostomy in cases
with neurological disease for in-hospital mortality.
Comorbid congenital heart diseases had been reported in
10e58% of patients with airway malacia, and up to one third
of these patients required surgical intervention.4,6e10 In addi-
tion, the incidence of airway malacia with comorbid genetic
disorders and congenital anomalies including Down syn-
drome, VACTERL association, and 22q11.2 microdeletion
syndrome have been reported in infants with an incidence
ranging from 8% to 52%, which is consistent with our
results.6e10 For patients with impaired cardiac function
resulting from congenital heart diseases, airway anomalies
may further affect oxygenation.6 In our analysis, congenital
heart diseases and congenital anomalies were two of the five
most commonly diagnosed comorbidities at death. The addi-
tive effect of congenital heart diseases and other congenital
anomalies may therefore worsen the symptoms of LTBAs and
cause death.
A significantly higher in-hospital mortality rate in the late
LTBA group compared with the early LTBA group was
demonstrated in the present study. The causalities between
early and late LTBA groups may be different. Different from
the early LTBA group, infants of the late LTBA group may
have had delayed diagnosis due to indistinct symptoms or later
onset of the disease. It is possible that some late LTBAs were
secondary to respiratory complications during their hospitali-
zations. In this study, we have demonstrated that infants in the
late LTBA group more commonly had neurological diseases
and a tendency to have more common perinatal infections,
musculoskeletal anomalies, and esophageal diseases which are
frequently complicated with respiratory problems (Table
2).The multiple logistic regression analysis also showed that
perinatal disease, cardiovascular anomaly, other congenital
226 K.-L. Lee et al. / Journal of the Chinese Medical Association 79 (2016) 221e227anomaly, and neurological disease were all significant risk
factors in addition to age for in-hospital mortality (Table 3).
These findings support that underlying diseases play important
roles in late LTBAs and in-hospital mortality. Later diagnosis
usually results in later treatment. Hence, underlying complex
diseases and later-diagnosed LTBAs are all related risk factors
for in-hospital mortality in diseased infants.
The problems of the early LTBA group may more
commonly be congenital, so that their symptoms onset earlier,
and correct diagnosis and treatment are earlier. Furthermore,
these infants had fewer underlying diseases compared to the
late LTBA group, so their airway problems were more easily
controlled and the in-hospital mortality rate was lower.
To our best knowledge, the influence of age difference in
diseased young patients' mortality has not been reported in in-
fants with airway anomalies. However, a similar finding that
older young children (12e23months old) had a higher mortality
risk than younger children (0e11months old) with abusive head
trauma was reported in the US recently.27 Therefore, age may
play an important role in the outcome of young children's dis-
eases. We suggest taking the patient's age into consideration in
predicting outcome in young infants with LTBAs, and for future
studies of other young children's diseases.
There are some limitations in this study. Firstly, we only
analyzed the hospitalization datasets, and LTBAs and comor-
bidities could have been underdiagnosed because the mild
forms may have been treated only in an ambulatory setting.
Secondly, the ICD-9-CM code 748.3 includes different types
of anomalies, including malacia, dysgenesis, and stenosis,
from the larynx, trachea, and bronchial airways. We did not
have enough information to identify the types of LTBAs.
Thirdly, the insurance claim data did not include the patients'
history or laboratory results, so the disease severity could not
be taken into consideration in the analysis. Fourthly, our study
datasets could not provide detailed information about patients'
managements which might also play a role in the patients'
outcome. Lastly, the mortality case number (n ¼ 47) is rather
low compared to surviving cases (n ¼ 1225), and we should be
very careful in interpreting the ORs for in-hospital mortality.
Therefore, further studies will be necessary to elucidate the
points limited by the claims data of Taiwan's NHIRD.
In conclusion, most infants with LTBAs were initially
diagnosed and hospitalized when they were aged 3 months and
younger. The risk factors for in-hospital mortality of the young
children with LTBAs during their first 5 years of life included
being diagnosed and treated at an age of 4 months and older,
and having perinatal disease, cardiovascular anomalies, other
congenital anomalies, and neurological diseases. Therefore,
clinical physicians should pay attention to small infants with
upper airway symptoms and treat them aggressively, espe-
cially in those with underlying complex diseases.
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